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Table 6 Comparisons of hemodynamics of uremic hypertensive group and hypertensive group (x  s).
Groups High volume Hyperkinetic High volume combined
with hyperkinesis
High volume combined hyperkinesis
and high resistance
High resistance
No. % No. % No. % No. % No. %
Uremia 20 19.2 3 2.9 45 43.3 14 13.5 7 5.8
Hypertension 4 5.3 1 1.3 25 32.9 25 32.9 11 14.5
c2 7.821 0.497 1.989 9.771 3.890
P value 0.005 0.481 0.158 0.002 0.049
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Table 7 Logistic regression analysis of factors leading to uremic hypertension.
Factors c2 P value OR 95% confidence interval of OR
Age 14.804 0.000 1.063 0.931～1.195
CO 26.303 0.000 3.436 3.361～3.511
EF 10.658 0.001 1.409 1.225～1.593
LSV 4.904 0.027 1.012 0.612～1.412
VFC 11.644 0.001 3.235 3.067～3.403
CVP 21.473 0.000 1.306 1.215～1.397
MIM 14.232 0.000 1.005 0.867～1.143
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F-actin Rearrangement is Involved in Decreased Cell-surface Expression
of Slo1 and BKCa Channel Inhibition Caused by Hypoxia in a Conditionally
Immortalized Human Podocyte Cell Line
Rui Zhang
Harbin Medical University, Harbin, Heilongjiang, China
There is much evidence to show that hypoxia and ischemia compromise
the structure and function of podocytes. Chronic hypoxia involved in
nephrosclerosis is an alternative mechanism for the pathogenesis of
rapidly progressive glomerulonephritis. Large-conductance Ca2+ activated
K+ channels (BKCa channels) encoded by the Slo1 gene are characterized
as mechanosensitive and oxygen-sensitive channels in podocytes. Howev-
er, whether BKCa channels are involved in the podocyte response to
chronic hypoxia and the possible underlying mechanisms remain unclear.
A conditionally immortalized human podocyte cell line transfected with
the temperature-sensitive SV40 gene construct was cultured and differ-
entiated. We used the patch clamp technique to show that the exposure
of human podocytes to 2% O2 for 24 hours causes a significant reduction in
BKCa channel currents. FITC-phalloidin staining display that hypoxia and
cytochalasin D cause F-actin rearrangement and depolymerization in
podocytes. Furthermore, cell-surface biotinylation assays indicate a
marked decrease in surface expression of Slo1 in anoxia. However, the to-
tal amount of Slo1 expression in whole cell has no significant variation af-
ter hypoxic treatment. Thus, we conclude that chronic hypoxia inhibits
podocytes BKCa channel currents by F-actin rearrangement and reduced
Slo1 expression on cell membrane. These findings provide new insight
into the mechanism underlying the cellular responses of podocytes to
hypoxia.http://dx.doi.org/10.1016/j.hkjn.2015.08.083
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Objective: Our study aimed to detect the epidemiology, compliance and
treatment of hypertension in CKD population by a multicenter cross-
sectional investigation.
Methods: We conducted a multicenter, cross-sectional study in 22 hospitals
throughout China from Feb-2013 to Jan-2014 to investigate the prevalence,
awareness and treatment of hypertension by blood pressure measurement
and questionnaire. Single variant analysis and multivariate Logistic regres-
sion were used to determine the associated factors.
Results: The cross-sectional study recruited 6079 CKD patients from CKD stages
1e5. 4328 had hypertension (71.2%) and 4054 were receiving medication.Compared to CKD stage 1, patients with CKD stages 2, 3a, 3b, 4 and 5 had
increased risk of hypertensionof 1.3, 2.4, 2.68, 5.26 and13.35 fold, respectively.
Patients ofolderage (> 65 vs.< 45;ORZ 3.7, 95%CI 2.9e4.71), family historyof
hypertension (ORZ 2.63, 95% CI 2.16e3.22), diabetes (ORZ 2.14, 95% CI
1.57e2.93), obesity (BMI > 28 kg/m2; ORZ 1.91, 95% CI 1.43e2.57), dyslipide-
mia (ORZ 1.52, 95% CI 1.26e1.82), hyperuricemia (ORZ 1.35, 95% CI
1.11e1.64) or proteinuria (urine albumin/creatinine > 300 mg/g; ORZ 1.3,
95% CI 1.03e1.65) had higer prevalence of hypertension. 41.1% hypertensive
CKD who were taking antihypertensive medication controlled their BP < 140/
90 mmHg. For hypertensive CKD patients < 60 years old and with proteinuria,
control rate was 16.7% (< 130/80 mmHg). Calcium channel blockers (CCB)
were the most frequent antihypertensive agents used by CKD patients (72.9%),
followed by ARB (53.9%), b-blockers (24.4%) and ACEI (16.4%). Patients using
ARB (ORZ 1.64, 95% CI 1.38e1.94), ACEI (ORZ 1.51, 95% CI 1.22e1.87) or
HBPM (ORZ 1.3, 95% CI 1.08e1.56) controlled BP better. Hypertensive CKD pa-
tients< 60yearsoldandwithproteinuria, female(ORZ 1.78,95%CI1.31e2.41),
patients with HBPM use (ORZ 1.53, 95% CI 1.03e2.27) controlled BP better.
Conclusion: The multicenter cross-sectional study showed that prevalence
of hypertension in CKD was high but with poor control. ACEI/ARB use and
HBPM could help with hypertension control.http://dx.doi.org/10.1016/j.hkjn.2015.08.084
